Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeted Radionuclide Therapy: Current Landscape and Combination Approaches to Improve Oncology Outcomes.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Radioluminescence microscopy of tumor organoids enabled by a reconfigurable high-resolution imaging setup.

EJNMMI research·2026
Same author

Toward a Biopsy-Free Diagnosis of Prostate Cancer: Potential of Combined <sup>18</sup>F-Flotufolastat PSMA PET and mpMRI.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Imaging the hallmarks of cancer.

Nature reviews. Cancer·2026
Same author

Impact of different PSMA PET-based eligibility criteria on outcome of [<sup>177</sup>Lu]Lu-PSMA radioligand therapy using [<sup>18</sup>F]rhPSMA-7/[<sup>18</sup>F]rhPSMA-7.3 (Flotufolastat).

EJNMMI research·2026
Same author

The role of 18F-FDG PET/CT in spinal infections: A comprehensive diagnostic tool.

Brain & spine·2026

Related Experiment Video

Updated: Jun 24, 2026

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET
09:03

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET

Published on: October 22, 2019

Measuring response with FDG-PET: methodological aspects.

Martin Allen-Auerbach1, Wolfgang A Weber

  • 1Department of Molecular and Medical Pharmacology, Ahmanson Biological Imaging Center, UCLA David Geffen School of Medicine, Los Angeles, CA 90095-6942, USA. mauerbach@mednet.ucla.edu

The Oncologist
|April 10, 2009
PubMed
Summary

Fluorodeoxyglucose positron emission tomography (FDG-PET) offers advantages over anatomical imaging for assessing cancer treatment response. This review covers practical aspects of FDG-PET quantification for oncologists to guide therapy adjustments.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging
08:31

Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging

Published on: July 1, 2021

Related Experiment Videos

Last Updated: Jun 24, 2026

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET
09:03

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET

Published on: October 22, 2019

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging
08:31

Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging

Published on: July 1, 2021

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Medical Imaging

Background:

  • Fluorodeoxyglucose positron emission tomography (FDG-PET) is utilized for evaluating tumor response to chemotherapy and radiation therapy across various malignancies.
  • FDG-PET images tumor metabolism and therapy-induced changes, offering superior assessment capabilities compared to traditional anatomical imaging.
  • Emerging research highlights FDG-PET's potential for early prediction of treatment response, enabling timely therapeutic modifications.

Purpose of the Study:

  • To equip oncologists with fundamental knowledge of practical positron emission tomography (PET) quantification techniques.
  • To provide insights into leveraging FDG-PET for effective cancer treatment monitoring and adjustment.

Main Methods:

  • Review of existing literature on FDG-PET applications in oncology.
  • Analysis of studies demonstrating the efficacy of FDG-PET in assessing treatment response.
  • Focus on the principles and practicalities of quantitative PET imaging.

Main Results:

  • FDG-PET demonstrates significant advantages over anatomical imaging in evaluating treatment response.
  • Early prediction of tumor response is achievable with FDG-PET during therapy.
  • Quantitative PET parameters can guide treatment decisions and adjustments.

Conclusions:

  • FDG-PET is a valuable tool for monitoring cancer treatment efficacy.
  • Quantitative analysis of FDG-PET scans allows for personalized and adaptive cancer therapy.
  • Oncologists can utilize PET quantification to optimize patient outcomes.